COMPASS Pathways plc (NASDAQ:CMPS) Receives Consensus Recommendation of “Buy” from Analysts

Shares of COMPASS Pathways plc (NASDAQ:CMPS) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $33.60.

A number of brokerages have commented on CMPS. Royal Bank of Canada decreased their price target on shares of COMPASS Pathways from $23.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. HC Wainwright decreased their target price on shares of COMPASS Pathways from $120.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, Maxim Group cut their price target on COMPASS Pathways from $22.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, November 1st.

COMPASS Pathways Price Performance

CMPS stock opened at $3.37 on Tuesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 8.91 and a quick ratio of 8.91. The company’s 50-day moving average is $4.41 and its 200-day moving average is $5.92. The stock has a market capitalization of $230.58 million, a PE ratio of -1.53 and a beta of 2.27. COMPASS Pathways has a 1 year low of $3.16 and a 1 year high of $12.75.

COMPASS Pathways (NASDAQ:CMPS) last announced its quarterly earnings results on Thursday, October 31st. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.60) by $0.04. During the same period in the prior year, the business posted ($0.67) earnings per share. Equities research analysts expect that COMPASS Pathways will post -2.33 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in CMPS. Polar Asset Management Partners Inc. increased its stake in COMPASS Pathways by 83.3% in the 3rd quarter. Polar Asset Management Partners Inc. now owns 567,600 shares of the company’s stock valued at $3,576,000 after buying an additional 258,000 shares during the last quarter. Logos Global Management LP increased its position in shares of COMPASS Pathways by 349.3% during the second quarter. Logos Global Management LP now owns 1,159,030 shares of the company’s stock valued at $7,001,000 after acquiring an additional 901,050 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in COMPASS Pathways by 1,518.4% during the second quarter. Renaissance Technologies LLC now owns 263,800 shares of the company’s stock worth $1,593,000 after acquiring an additional 247,500 shares during the period. Sio Capital Management LLC lifted its holdings in COMPASS Pathways by 211.7% during the third quarter. Sio Capital Management LLC now owns 914,639 shares of the company’s stock worth $5,762,000 after acquiring an additional 621,222 shares during the period. Finally, Walleye Capital LLC purchased a new position in COMPASS Pathways in the third quarter worth $2,126,000. 46.19% of the stock is owned by institutional investors.

About COMPASS Pathways

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.